TD Cowen Maintains Buy on Biote, Lowers Price Target to $2

Benzinga · 2d ago
TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.